(1S,3R)-N-{(3S,10S,12S,13R,17R)-12-Hydroxy-17- [(R)-5-hydroxypentan-2-yl]-10,13-dimethylhexa- decahydro-1H-cyclopenta[a]phenanthren-3-yl}- adamantane-1-carboxamide 0.25-hydrate
保存先:
| 著者: | , , , , |
|---|---|
| フォーマット: | artículo original |
| 出版日付: | 2022 |
| その他の書誌記述: | The title compound, C 35H 57 NO 3 0.25H 2O, was synthesized from deoxycholic acid followed by a protection, a Mitsonobu substitution, a Staudinger reduction, formation of an amide and final reduction in the lateral chain. The compound crystallizes in the P1 space group with four steroid molecules and one water molecule in the triclinic cell unit. The crystal structure features O—H O hydrogen bonding. The crystal studied was refined as a non-merohedral twin |
| 国: | Kérwá |
| 機関: | Universidad de Costa Rica |
| Repositorio: | Kérwá |
| 言語: | Inglés |
| OAI Identifier: | oai:kerwa.ucr.ac.cr:10669/87554 |
| オンライン･アクセス: | https://iucrdata.iucr.org/x/issues/2022/10/00/bt4124/index.html https://hdl.handle.net/10669/87554 |
| キーワード: | Química Cristalografía biological activity crystal structure bile salts |